Sinocelltech Group Ltd (SHG:688520) — Market Cap & Net Worth
Market Cap & Net Worth: Sinocelltech Group Ltd (688520)
Sinocelltech Group Ltd (SHG:688520) has a market capitalization of $2.23 Billion (CN¥15.21 Billion) as of June 22, 2026. Listed on the SHG stock exchange, this China-based company holds position #5962 globally and #1231 in its home market, demonstrating a 0.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sinocelltech Group Ltd's stock price CN¥34.16 by its total outstanding shares 445335714 (445.34 Million). Review Sinocelltech Group Ltd balance sheet liabilities to assess the company's total debt and financial obligations.
Sinocelltech Group Ltd Market Cap History: 2020 to 2026
Sinocelltech Group Ltd's market capitalization history from 2020 to 2026. Data shows change from $2.97 Billion to $2.23 Billion (-11.92% CAGR).
Sinocelltech Group Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sinocelltech Group Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.94x
Sinocelltech Group Ltd's market cap is 0.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
21.09x
Sinocelltech Group Ltd's market cap is 21.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.97 Billion | $328.17K | -$712.50 Million | 9045.27x | N/A |
| 2021 | $3.81 Billion | $134.39 Million | -$866.85 Million | 28.34x | N/A |
| 2022 | $3.95 Billion | $1.02 Billion | -$519.00 Million | 3.86x | N/A |
| 2023 | $3.51 Billion | $1.89 Billion | -$396.02 Million | 1.86x | N/A |
| 2024 | $2.36 Billion | $2.51 Billion | $111.95 Million | 0.94x | 21.09x |
Competitor Companies of 688520 by Market Capitalization
Companies near Sinocelltech Group Ltd in the global market cap rankings as of June 22, 2026.
Key companies related to Sinocelltech Group Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #571 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.70 |
| #571 | Argen-X | BR:ARGX | $47.14 Billion | €773.80 |
Sinocelltech Group Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Sinocelltech Group Ltd's market cap moved from $2.97 Billion to $ 2.23 Billion, with a yearly change of -11.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.23 Billion | -21.13% |
| 2025 | CN¥2.82 Billion | +19.54% |
| 2024 | CN¥2.36 Billion | -32.75% |
| 2023 | CN¥3.51 Billion | -11.11% |
| 2022 | CN¥3.95 Billion | +3.68% |
| 2021 | CN¥3.81 Billion | +28.32% |
| 2020 | CN¥2.97 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Sinocelltech Group Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.23 Billion USD |
| MoneyControl | $2.23 Billion USD |
| MarketWatch | $2.23 Billion USD |
| marketcap.company | $2.23 Billion USD |
| Reuters | $2.23 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sinocelltech Group Ltd
Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell… Read more